Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasms × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 502 Leukemia 258 Precursor Cell Lymphoblastic Leukemia-Lymphoma 202 Lymphoma 144 Myelodysplastic Syndromes 97 Burkitt Lymphoma 80 Leukemia, Monocytic, Acute 78 Lymphoma, Non-Hodgkin 76 Congenital Abnormalities 76 Leukemia, Myelomonocytic, Acute 74 Leukemia, Erythroblastic, Acute 69 Lymphoma, Large B-Cell, Diffuse 68 Leukemia, Megakaryoblastic, Acute 66 Lymphoma, Mantle-Cell 61 Recurrence 59 Lymphoma, Follicular 42 Leukemia, Myelomonocytic, Chronic 41 Hodgkin Disease 40 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 33 Anemia, Refractory, with Excess of Blasts 32 Myeloproliferative Disorders 30 Leukemia, Lymphocytic, Chronic, B-Cell 30 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Eosinophilic, Acute 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Basophilic, Acute 20

Interventions

Trastuzumab 527 Paclitaxel 501 Cyclophosphamide 482 Docetaxel 425 Capecitabine 359 Letrozole 312 Fulvestrant 276 Doxorubicin 254 Carboplatin 241 Tamoxifen 227 Anastrozole 189 exemestane 182 Radiotherapy 181 Epirubicin 179 Bevacizumab 172 Vinorelbine 151 Lapatinib 151 Gemcitabine 149 pembrolizumab 145 pertuzumab 143 palbociclib 135 Exercise 116 Albumin-Bound Paclitaxel 107 Magnetic Resonance Spectroscopy 104 Fluorouracil 104 eribulin 99 130-nm albumin-bound paclitaxel 95 Everolimus 90 Taxes 85 Cisplatin 84

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645839 2019-06-12

DEPOSEIN

Centre Oscar Lambret

Phase 3 Completed

Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡